A 44-year-old member asked:
What are the most promising treatments for t-cell prolymphocytic leukemia?
1 doctor answer
Dr. Herbert Duvivier answered
32 years experience in Hematology and Oncology
Campath (alemtuzumab): T-cell pll is considered a relatively chemotherapy resistant disease. Although treatments with chop, cop, fludarabine, etc are used they usually do not result in long term control of the disease. More recently Campath (alemtuzumab) has been used with increased success. Lastly, bone marrow transplant once in remission is being looked at as a possible consolidation therapy with some promise.
Answered on Jun 24, 2014
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more. Get help now:
People also searched for:
Connect by text or video with a U.S. board-certified doctor now — wait time is less than 1 minute!